Stick to the Rules<br />By Rev Shark<br />RealMoney.com Contributor<br />2/17/2010 8:27 AM EST<br /><br /> To study the abnormal is the best way of understanding the normal.<br /> -- William James<br /><br />The main focus of my posts recently have been whether the market is going to continue to act like it did last year. If it is, then the way to play it is pretty easy: We just need to buy every dip and then wait for a new high. The consistent and immediate recovery of the market favored those who were unhesitating in their bullishness.<br /><br />This year we started off with strong seasonal action in the first half of January that took us to new highs. We then had a sharp selloff of an attempted bounce and then rolled over again. We have been trying to recover from the second breakdown for the last seven trading days and have nearly done so after the good move yesterday.<br /><br />Since the breakdown we have had two particularly strong days that helped the bulls to believe that another "V"-shaped recovery was on the way. The first day was on Feb. 2, but there was no follow-through, which was the first significant bounce failure since June and July of 2009.<br /><br />We are now undergoing the second bounce attempt and after yesterday the bulls are feeling quite positive. Although breadth was quite good and we cut through some overhead resistance, volume was quite light and it didn't qualify as a technical follow-through day as defined by Investor's Business Daily. IBD still considers the market to be undergoing a correction.<br /><br />The question here is obvious. Do we struggle to trade through overhead resistance at 1100 to 1108 on the S&P 500 or do we act like we did last year and just go straight back up without any concern for the weak technical action behind this rally?<br /><br />If the market had acted more normally last year, this question wouldn't be hard to answer at all. Under normal circumstances we simply can't trust the market to go straight back up on declining volume. The market violates the "rules" of technical analysis quite often, but if we stick to the odds then we just can't expect the market to move in that fashion.<br /><br />Many bulls are ready to bet this market is going to do exactly what it did last year and go straight back up, leaving the skeptics and bears on the sidelines and feeling like fools again. It is very easy to see why market players want to embrace that idea. We saw it so many times in the last eight months or so that it looks like it is the standard rule and not that exception.<br /><br />I'd love to trust in the idea that this market will continue to act abnormally, but it violates my trading style and my discipline. If the market does continue to go straight up to new highs on light volume, then I'm going to be on the wrong side of the trade and will have to take some stop losses and will underperform. That is the price that we pay when we try to apply rules in an environment that is often irrational. As long as we are aware that we will often be wrong and are willing to take steps to keep our losses small, we will be OK in the longer run, but it does cause a lot of frustration and anxiety in the short run.<br /><br />So we are at an interesting juncture yet again. Will the market continue to act in an abnormal fashion, or will the traditional rules of technical analysis kick in? I have to stick with the TA rulebook, and that means looking for this bounce to fail.<br /><br />In the early going we have some upside follow-through. Overseas markets acted well and we have some good earnings from Deere. The bulls are feeling good and are looking quite confident. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: WFMI +9.1% (also upgraded to Overweight at JPMorgan), PACR +8.9%, DE +7.8%, CSTR +7.7%, TCX +7.5%, LZB +6.9%, PLAB +6.8% (light volume), HL +4.5%, GIVN +4.5%, MIG +4.5% (light volume), TLB +4.2% (also Talbots and BPW agree to technical amendment to merger agreement to provide greater assurance to BPW shareholders regarding value of merger consideration ), UCTT +3.0%, WINN +3.0%, ING +2.8%, DVN +2.0%, HTS +1.9%, MRH +1.0%... Select financial names showing strength: LYG +2.5%, C +2.1% (Soros doubled gold ETF investment, buys Citi - Reuters), PUK +1.8%, DB +1.7%, RBS +1.7%, HBC +1.3%, BAC +1.1%... Other news: RZ +25.0% (receives approval for $32.99 million U.S. Treasury Grant), CYCC +10.4% (light volume; reports new study in clinical cancer research demonstrates potential for Cyclacel's seliciclib in treating breast cancer resistant to hormone therapy), DVAX +9.3% (receives Canadian approval to conduct Phase 3 trials), NLST +5.8% (announces that a major OEM has commenced volume consumption of NetVault-NV, a flash memory based non-volatile cache memory subsystem targeting RAID storage applications), UEC +5.7% (continued strength), DISCA +5.6% (will replace Pepsi Bottling Group in the S&P 500 index), HGRD +5.4% (still checking), AIXG +5.2% (discloses multiple system order), SAY +4.5% (still checking), NAV +4.0% (awarded $752 mln contract for MaxxPro Dash MRAP vehicles), BYI +2.8% (l replace PepsiAmericas in the S&P MidCap 400 index), CAT +2.0% (trading higher in sympathy with DE), CHK +1.8% (provides Operational Update), SNY +1.8% (still checking), POT +1.6% (Credit Suisse reviews North American January fertilizer inventory data; demand has been strong for all three nutrients), NOK +1.2% (still checking)... Analyst comments: SNDK +4.1% (upgraded to Overweight at Morgan Stanley), ANAD +3.6% (upgraded to Outperform from Market Perform at Northland Securities), JOYG +2.1% (initiated with a Buy at BB&T Capital Mkts), BUCY +1.4% (initiated with a Buy at BB&T Capital Mkts), BCS +1.3% (upgraded to Buy at RBS).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: RICK -10.8% (also the co and VCGH enter into letter of intent to merge to form largest publicly traded N. American Gentlemen's Club Owner), OC -4.3% , VCLK -4.3% , RAX -3.0% , AMMD -2.7% (also announces sale of Her Option global endometrial ablation product line), CPB -2.4% , IAG -1.5% (light volume), HWAY -1.4%... Other news: SIRO -5.6% (announced that it is filing a prospectus supplement to its existing shelf registration statement with the U.S. SEC relating to an underwritten public offering by Sirona Holdings Luxco S.C.A. of 7,000,000 shares of its common stock), DSCI -4.0% (prices a 972K share common stock offering at $5.50/share), PRAA -2.9% (announces public offering of 1 mln shares of its common stock), GSIC -2.4% (announces offering of common stock by selling stockholder), BP -2.1% (trading ex dividend)... Analyst comments: CTXS -0.8% (initiated with a Sell at Citigroup).